accountthe drugmaker moved to make up for the expected losses by paying $68 billion in 2009 to acquire Wyeth, it also has had four setbacks this year in developing its research pipeline. This seems sudden, said Les Funtleyder, a Miller Tabak & Co. portfolio...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Names Read CEO to Replace Weary Kindler
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account